Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 17:12:788772.
doi: 10.3389/fphys.2021.788772. eCollection 2021.

Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium

Affiliations
Review

Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium

Zhu Xue et al. Front Physiol. .

Abstract

As a highly dynamic tissue, the endometrium is periodically shed in response to the secretion of estrogen and progesterone. After menarche, the endometrium of healthy women proliferates and differentiates under the action of steroid hormones (e.g., 17β-estradiol and progesterone) that are secreted by the ovaries to provide appropriate conditions for embryo implantation. Polycystic ovary syndrome (PCOS), a prevalent endocrine and metabolic disorder in reproductive-aged women, is usually associated with multiple cysts within the ovaries and excess levels of androgen and is characterized by hirsutism, acne, menstrual irregularity, infertility, and increased risk of insulin resistance. Multiple factors, such as anovulation, endocrine-metabolic abnormalities, and inflammation, can disrupt the endometrium in PCOS patients and can lead to endometrial hyperplasia, pregnancy complications, or even cancer. Despite many recent studies, the relationship between PCOS and abnormal endometrial function is still not fully understood. In this review, we investigate the correlation of PCOS patient endometrium with anovulation, hyperandrogenemia, insulin resistance, progesterone resistance, and inflammatory cytokines, aiming to provide a theoretical basis for the treatment of disorders caused by endometrial dysfunction in PCOS patients.

Keywords: anovulation; endometrium; hyperandrogenemia; inflammatory cytokines; insulin resistance; polycystic ovary syndrome; progesterone resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The clinical phenotype of PCOS and the related mechanisms of endometrial physiology and pathology.
Figure 2
Figure 2
The pathological mechanism of HA acts on the endometrium of PCOS.
Figure 3
Figure 3
The PI3 Kinase-Akt signaling pathway.

Similar articles

Cited by

References

    1. Abuelezz N. Z., Shabana M. E., Abdel-Mageed H. M., Rashed L., Morcos G. N. B. (2020). Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: insights on PI3K/AkT/mTOR and TNF-α modulations. Life Sci. 256:118003. doi: 10.1016/j.lfs.2020.118003, PMID: - DOI - PubMed
    1. Albaghdadi A. J. H., Kan F. W. K. (2021). Therapeutic potentials of low-dose tacrolimus for aberrant endometrial features in polycystic ovary syndrome. Int. J. Mol. Sci. 22:2872. doi: 10.3390/ijms22062872, PMID: - DOI - PMC - PubMed
    1. Alkhuriji A. F., Al Omar S. Y., Babay Z. A., El-Khadragy M. F., Mansour L. A., Alharbi W. G., et al. . (2020). Association of IL-1β, IL-6, TNF-α, and TGFβ1 gene polymorphisms with recurrent spontaneous abortion in polycystic ovary syndrome. Dis. Markers 2020:6076274. doi: 10.1155/2020/6076274, PMID: - DOI - PMC - PubMed
    1. Al-Sabbagh M., Lam E. W.-F., Brosens J. J. (2012). Mechanisms of endometrial progesterone resistance. Mol. Cell. Endocrinol. 358, 208–215. doi: 10.1016/j.mce.2011.10.035, PMID: - DOI - PubMed
    1. Andersson C., Oji Y., Ohlson N., Wang S., Li X., Ottander U., et al. . (2014). Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma. Cancer Med. 3, 909–918. doi: 10.1002/cam4.244, PMID: - DOI - PMC - PubMed